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I am thankful for the great honor and privilege
you have bestowed on me in allowing me to serve as
your President during the past year. It is particularly
humbling to be standing before you, my profession-
al peers, at this unique moment in time—June 7,
1999. There are 207 days, 12 hours, and 27 minutes
left in this millennium, and the clock is ticking. As
time runs out on this millennium, it seems appropri-
ate to reflect on the issue of time and to review the
past, take stock of the present, and think about the
future and the future of vascular surgery. But first, I
would like to reflect on what is most important in
my own past, present, and future, and that is my
family, my heritage, and my profession.
My family came to this country 54 years ago as
refugees of World War II. I grew up in the parish
house of the Latvian church in Brooklyn, NY, where
my father to this day continues his commitment to
his profession, the ministry, and devotes himself to
the needs of the members of his congregation.
As has been the case for millions of other
refugees from around the world, the terrible misfor-
tune of war and devastation also provided an incred-
ible opportunity in America. I am grateful for my
good fortune to have grown up in America and am
mindful of my even greater fortune of the love and
support of a wonderful family. Please permit me to
pause for a moment here to thank my family: my
parents, who brought me to this country and self-
lessly supported my growth and education; my won-
derful, loving wife, Zinta, who has stood by my side,
unfailingly supporting my professional career while
nurturing our family in two cultures, Latvian and
American; and my three wonderful children, Daina,
Sascha, and Karina, all of whom speak fluent
Latvian. There are no adequate words to thank you,
at least not in English. Mils, mils paldies.
I would also like to thank my mentors: Dr
William Fry, who set for me the standard of clinical
excellence—surgical precision and patient care above
all else; Dr David Skinner, who set for me the stan-
dard for academic excellence—combining research,
teaching, and patient care into the everyday life of an
academic surgeon; and Dr Seymour Glagov, who set
for me the standard for basic investigation—the
understanding of the fundamental biologic and
pathologic processes of vascular disease. I am grate-
ful for the support and inspiration of my superb col-
leagues on the faculties of the University of Chicago
and Stanford University and for the creativity, ener-
gy, and commitment of the students, residents, and
vascular surgery fellows with whom I have worked.
They are the real future of vascular surgery.
Meanwhile, in Latvia, the Soviet occupation
would last 50 years. Many of those in my family who
were not killed by the Communists were deported
to Siberia. Their opportunities were quite different
from mine. This became a stark reality for me when
I first visited Latvia in 1986, then still an occupied
country under Soviet rule. For the first time, I met
my relatives—my first cousins, who were my age,
and their children, who were my children’s ages. We
saw how different our lives were as a result of fate
and government systems. We sometimes take for
granted the incredible freedom and opportunities
we enjoy in America. We must guard and protect our
individual freedom against ever-increasing govern-
mental regulation and control. I am filled with a
great sense of gratitude for this great land of oppor-
tunity that is now my home, the United States, and
a desire to give something back to my native coun-
try, Latvia, and to those less fortunate than I.
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We have in our audience today five vascular sur-
geons from Latvia. Their situation in Latvia is a far
cry from what we enjoy in the United States. Doctors
in Latvia do not enjoy the wealth, status, and power
that we do. They work in antiquated hospitals with
inadequate resources and supplies. They receive mea-
ger salaries, and most of them must have second jobs
to pay the bills. Despite this sad state of affairs, these
are professional, dedicated, capable physicians. They
work hard and provide good medical care. They did
not go into medicine for the money. They are in it for
the reasons we all went into medicine in the first
place—to take care of the sick. Perhaps we can gain
some perspective from our Latvian colleagues as we
consider the issues that face us today.
Despite having the best healthcare system in the
world with the knowledge, resources, technology, and
capability to cure disease like never before, we are sur-
rounded by a sense of doom and gloom. Doctors are
frustrated and unhappy, patients are frustrated and
unhappy, and the healthcare system is in turmoil, not
because of factors within medicine but because of
external economic forces that are threatening medi-
cine. The managed care revolution, with its inherent
focus on cost cutting and profit seeking, has dramati-
cally altered the way medicine is practiced in America.
The medical profession is under siege. It seems as
though the healthcare of our nation, which society
always had entrusted to medical professionals, has
now been placed in the hands of financial people:
chief executive officers, chief financial officers, admin-
istrators, and business managers.
The economic crisis in healthcare has raised many
important questions. Will medicine play a major role
in determining the health of society in the future? Will
patients look to their doctors for advice, or will
healthcare analysts and financial planners choose
treatment? How can we resolve the conflicts between
professionalism and managed care? Will the doctor of
the 21st century be a true professional or merely the
instrument of an insurance company trying to place
barriers before patients and restrict access to care?
These are the fundamental questions that we must
address in this age of turmoil and rapid change to
understand where we are going in the future. And in
doing so, it seems to me, we can boil it down to three
key issues: time, money, and professionalism. Do we
have time to be physicians and surgeons? Will there be
enough money for medical care? Will the profession
of medicine survive?
First, let us consider time. A millennium seems
like an eternity. As a child, I remember how time
seemed to stand still. Summer vacation lasted forev-
er, and then the school year would never end. But
now, each passing year is a smaller and smaller per-
cent of my lifetime. A year passes in a moment. And
now time will run out in this millennium.
In a review of the past millennium, it is remark-
able not only how things have changed but also how
rapidly the rate of change has increased, particularly
in the last half of the last century of this millennium.
In our everyday lives today, we are using technology
that we did not even dream was possible just a decade
ago. Much of the technology is focused on labor-sav-
ing devices that would give us more time: machines,
tractors, vacuum cleaners, and dishwashers.
Just thirty years ago, the experts were assuring us
that, with advances in technology, our biggest chal-
lenge would be what to do with all the leisure time
we were going to have in the future. But the future
is now, and life for most of us has become so com-
plicated, rapid paced, and stressful that the idea of
leisure time has become antiquated. We have run
out of time. We want more time, but we cannot get
it. Time quickly disappears and is gone forever.
We need more time. We need time for our
patients. We need time for our families. We need time
for ourselves and for our everyday lives. We need time
for the profession of medicine and for the profession
of vascular surgery. The care of patients with vascular
disease requires time. As we lose time and get busier
and busier, we seem to be enjoying it less and less.
In this all-too-fast-paced environment, we must
take the time to stop and reflect, to reorganize our
priorities. What is really important to us as individu-
als, family members, physicians, and vascular sur-
geons? Why did we go into medicine in the first place?
It is no accident that the fastest-growing seg-
ment of the healthcare market is alternative medi-
cine. Patients seek out chiropractors, herbal and
Chinese medicine practitioners, and faith healers of
all types because they spend time with patients, pro-
vide them with information and hope, and give
them a role in their own healthcare decisions. We
must be there for our patients. We must provide the
time they need if we are to survive as the specialty
that provides care for patients with vascular disease.
The second critical issue is money. Just as we
have run out of time, we also seem to have run out
of money. In this era of managed care, health main-
tenance organizations do not manage care but man-
age costs. Both nonprofit and for-profit health main-
tenance organizations compete for patients largely
on the basis of price. They focus on the short term
by reducing monthly premiums to sign up as many
“covered lives” as possible and balance the equation
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by rationing care. This is particularly pernicious
when physicians are taken out of the decision loop
or, worse yet, when physicians are placed in positions
of conflict of interest by the use of economic incen-
tives to withhold care. Physician reimbursement pat-
terns provide a disincentive for physicians to spend
time with their patients. Whereas we have grown up
thinking that “time is money,” we now find that
“time is no money.”
In most professions, including the legal profes-
sion, services are billed on the basis of time spent.
This is not the case in medicine. We are being asked
to do more and are being paid less. This is particular-
ly true in vascular surgery. Vascular surgery services
are time intensive and were undervalued when the rel-
ative value unit (RVU) system was introduced in
1992. This is because vascular surgeons were not rep-
resented in the Hsaio studies, which set the relative
work values. Vascular society efforts to rectify this
problem, led by Hugh Trout, were blocked by the
Health Care Financing Administration (HCFA) in
1993. The further decline in Medicare reimburse-
ments that was mandated by the Balanced Budget Act
of 1997 is now resulting in a crisis for vascular surgery.
In September of last year, the Joint Vascular
Societies again appealed to HCFA for revision of
Medicare payment policies. Drs Zwolak and Oblath
presented extensive and convincing data to the
Administrator of HCFA, Nancy Min-DeParle, that
the medicare fee schedule reductions imposed on vas-
cular surgery were a severe threat to the future of
high-quality vascular surgery. They pointed out that
the abrupt elimination of the separate surgical con-
version factor in 1998 cut 9% from our Medicare pay-
ments in a single year. We now face another 12%
reduction with resource-based practice expense.
Carotid endarterectomy, our most commonly per-
formed operation, is a good example. In 1992, the
global RVU was 35.26 with a typical payment of
$1200. In 2002, the total RVU will be 31.08. With
an adjustment for a 3% annual inflation rate and with
the unlikely assumption that the conversion factor will
not decrease further, the typical Medicare payment in
2002 will be only $800 in 1992 dollars, according to
a letter from R.W. Oblath et al, September 1998. This
represents an absolute payment reduction to the sur-
geon of 33% in a decade when all other medical
expenses have increased much faster than 3% inflation
and when, during the same period, inflation-adjusted
payments for evaluation and management services
increased substantially.
Our Governmental Relations Committee, head-
ed by Bob Zwolak and his team of Bob Oblath,
Hugh Trout, Tony Sidaway, Gary Seabrook, Craig
Kent, Denny Baker, and Carlo Dall’Olmo, has made
our voice heard in Washington and has made impor-
tant progress on our behalf. But the obstacles and
problems abound, with no real relief in sight.
Remember that 70% of our patients are Medicare
beneficiaries, so we depend on the medicare fee
schedule more than any other specialty. And in
Medicare, we now find ourselves in a zero sum game
in terms of healthcare economics. There is only a
finite sum of money available for Medicare patients.
The federal government has mandated no increase
in Medicare expenditures. In fact, they will decrease
dramatically as a result of the Balanced Budget Act
of 1997. Of the $127 billion that is to be saved over
5 years, $116 billion will come from reductions in
Medicare.1 The bottom line is that, to maintain
budgetary neutrality as the number of Medicare
beneficiaries inevitably increases, the conversion fac-
tor must decrease. It is no secret that we will work
harder and be paid less.
This change will be implemented by a progressive
reduction in the RVU reimbursement rate. We will
simply be paid less for the same amount of work. At
some point, if this trend continues, we will reach a
time when it no longer pays to deliver the service. Of
course, we cannot NOT take care of the patient. We
always have, and we always will. But at some point,
one goes out of business and stops practicing alto-
gether. It is not overstating the problem to contend
that the reductions in Medicare fees from 1992 to
2002 threaten to eliminate high-quality vascular
surgery. We are already at risk of losing our most valu-
able resources: wise and experienced vascular surgeons
with the largest practices. In the last few years, we have
seen many of our most skilled colleagues retire early
because of frustration over rapidly declining reim-
bursement. Perhaps even more worrisome is the fact
that we may not be able to nurture our “young,” our
students, residents, and fellows, to become future vas-
cular surgeons because of their fears, which, I might
add, are well justified, that after 7 or 8 years of post-
graduate training, they may not be able to pay off their
medical school debts and earn a reasonable living.
Given this bleak picture, one might ask, “Why
would anyone choose to go into vascular surgery?”
In fact, I believe there is a real danger that in the
future we may find that the brightest and most qual-
ified students and residents will choose fields other
than vascular surgery. The long hours required for
vascular surgery and inadequate compensation may
result in a decreasing number of vascular surgeons
and too few specialists capable of direct vascular
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repair. The future shortage of vascular surgeons may
be significantly worse than those numbers projected
by Dr Jim Stanley’s workforce study.2
These problems will be compounded by the eco-
nomic crisis that faces hospitals, particularly the aca-
demic health centers. Most major teaching hospitals
are now losing money, despite record numbers of
patients, operating rooms at capacity, and a demand
for services that is greater than ever. Some of the
nation’s most prestigious academic medical centers
report losses as high as $1 million a week.3 The
deficits are prompting massive layoffs of staff 4 and
reducing hospital bond ratings.5 Strategies that
involve mergers and acquisitions seem to be failing,6
and we are beginning to see bankruptcies of major
teaching facilities. Many teaching hospitals are
threatened.7 These are the very hospitals that are the
major providers of healthcare to the poor and indi-
gent. How will we meet this crying need? 
Furthermore, will there be funding for graduate
medical education? The National Bipartisan Com-
mission on the Future of Medicare disbanded in
March of this year. The commission fell one vote
short of the 11 needed to achieve the super majori-
ty necessary to endorse a proposed set of reforms to
Congress and the President. The plan by Com-
mission Chairman Senator John Beaux proposed,
among other reforms, to end the entitlement status
of the $2.2 billion direct and indirect Medicare
financing for graduate medical education. Such a
process would shift graduate medical education
financing to the annual appropriations process and
would threaten the financial stability necessary to
support residency programs that last from 3 to 7
years. Senator John D. Rockefeller IV, one of the
seven who voted against the plan, warned advocates
for teaching hospitals that the Medicare reforms
stand a good chance of being passed by the Senate.8
It seems no one wants to pay for medical education,
and the buck is being passed.
We therefore need to consider not only will any-
one want to go into vascular surgery, but also what
will be the teaching environment for future vascular
surgeons? This is a critical question for the future of
our profession.
What else does the future hold? The great
philosopher Yogi Berra once stated that “the future
ain’t what it used to be.” However, in many ways,
the future is dictated by what already has happened.
Consider, for example, the influence of birth rates.
We can know what will happen in the future simply
by knowing how many babies are born each year.
Add to this the immigration rate, and you will know
what the population of the country will be years into
the future.
Generation cycles, which have been tracked as far
back as the 1400s, occur every 40 years.9 In the
United States, immigration, rather than birth rate,
was the driving factor behind growth and generation
cycles before the early 1900s. A surge in the birth rate
from 1945 to 1965 along with a great increase in
immigration created the “baby boom generation”
that we hear so much about. This generation will be
four times the size of the previous generation. The
members of this generation are now at the peak of
their productivity and consumption. This is, to a large
extent, what is driving our current and prolonged
economic boom.9 But soon they will reach retirement
age, and these baby boomers will become Medicare
patients. They will spend less, and the economy will
decline. Advances in medicine, public health, and
nutrition have increased longevity, and this generation
will be the first generation that has not physically
toiled for 40 years before retirement. They will be in
better shape to have vascular disease. An individual
born in 1997 can expect to live to 76.5 years, about
29 years longer than a person born in 1900.
Thus, there is no question that the number of
elderly people and the number of patients with vas-
cular disease will increase markedly in the next mil-
lennium. One hundred years ago, only three million
Americans were more than the age of 65 years.
Today, 33 million Americans live beyond that age.
By the year 2040, the number of individuals in the
United States who are more than the age of 50 years
is expected to double, jumping from 70 million to
140 million.10 Today, there are roughly 38 million
Medicare beneficiaries, but by 2030, when the last
of the baby boomers will be 65 years old, there will
be 76 million Medicare beneficiaries. The demand
for vascular care will be unprecedented. We must
begin thinking about how we will meet this demand.
Again, will we have enough vascular surgeons, and
how will we pay for patient care?
If we do not address and solve these problems,
the losers will be the patients with vascular disease.
And from a societal standpoint, that is a major con-
cern—the prospect of not having qualified practi-
tioners to perform sophisticated, high-intensity vas-
cular surgery in the future. A decline in the quality of
vascular care will cause significant increases in costs to
the healthcare system. Will there be a significant
decrease in the quality of care? Will we see more
strokes, amputations, and ruptured aneurysms? Will
we see the day when major treatment decisions are
made on the basis of reimbursement patterns?
JOURNAL OF VASCULAR SURGERY
210 Zarins February 2000
Today, for example, a radiologist would be paid
more for venography and placement of an inferior
vena cava (IVC) filter than we would be paid for a
femoral-distal bypass grafting procedure that would
take 4 to 6 hours. Percutaneous catheter-directed
thrombolysis, angioplasty, and stenting pay about the
same as a ruptured aneurysm repair. Moreover, we
care for that patient for 90 days with in-hospital care,
intensive care unit care, and postoperative care, and
perhaps weekly follow-up visits in the clinic if wound
care is required, all for the same global fee. However,
the percutaneous interventional procedure can be
repeated the next day and the day after and full pay-
ment will be received for each procedure. It would be
a tragedy if the ultimate solution were to apply thera-
pies because of how they are reimbursed and to aban-
don those therapies that either are not reimbursed or
are reimbursed inadequately. The reimbursement
schedules should be fair and should reflect the time
and effort expended lest unintended consequences
occur that are not to the benefit of the patient.
What can we do to address these issues? First, 
we must bring public awareness to the problem.
Individual patients and doctors are already aware that
there is a problem. But this must become an issue for
Congress and for the President. In the future, the
most potent political force in our country will be
senior citizens, not only because they are so large in
number, but also because they are the one demo-
graphic group that consistently goes to the polls and
votes. Thus, the concerns of the senior citizens will be
heard and addressed. We must support our social and
legislative issues committee and educate our citizens
on the importance of vascular disease therapy. We
must work together with our interventional col-
leagues to ensure that a coding and reimbursement
system is in place that will properly pay for services
rendered and effort expended regardless of specialty.
We all must become involved and begin to address the
issues of supply and demand before the supply of vas-
cular surgeons runs out and the demands of our
senior citizens cannot be met. We must protect our
research and teaching environments and stimulate 
our students, our residents, and our fellows by being
role models in the profession of vascular surgery.
But all is not doom and gloom. I, for one, believe
that the problems will be addressed and solved—they
always are. Worsening problems will force change.
The aging population in future elections will demand
it, and science and technology will come to the rescue
with new and more effective treatment strategies.
Science and technology have always led the way.
The remarkable advances in genomics and molec-
ular biology and pharmacology will transform the
practice of medicine. The changes that we have wit-
nessed during the past few years in the rapidly
changing technology of the treatment of aortic
aneurysms, carotid artery disease, and peripheral
occlusive disease have made it clear that vascular
surgery will never be the same. Will we grow and
adapt, accommodating and embracing the technolo-
gy and changes, or will we let the world pass us by?11
We are on the cusp of a paradigm shift in vascular
care, which will be spurred by enormous increases in
demand. The decline in reimbursement for time-
intensive open surgery threatens this mode of thera-
py, but it will not disappear, and it will continue to
play a role in vascular surgery.
New technology, new imaging capabilities, and
web-based communication will revolutionize the way
people seek and find their doctors, the way we practice
and administer treatment to vascular patients, and the
way we are compensated. New technology has already
revolutionized the way we visualize blood vessels and
envision the treatment of vascular disease. Diagnostic
methods will be noninvasive, with complete three-
dimensional imaging of the vasculature that will soon
replace diagnostic angiography. We will be able to plan
and execute treatments in virtual reality and test their
effectiveness before instituting treatment.12 Catheter-
based treatments will largely replace open surgical pro-
cedures, and vascular surgical care will dramatically
change.13 Perhaps a large part of what we do will be
outpatient based. Outmoded methods of treatment
will be abandoned, not necessarily because they are
ineffective or risky, but because the patient will
demand the newer noninvasive methods. Witness the
growth of carotid stenting when a proven, effective
surgical therapy is available.
However, although new techniques and technol-
ogy are critical to the future of vascular surgery, we
must remember that technology is merely a tool.
The more complex and sophisticated treatment
options become and the more information and
choices become available to patients on the Internet,
the more people will need the wise counsel of a
knowledgeable doctor. They will have information
overload and will not know where to turn. There
will also be an enormous segment of society that will
be left behind in the information age. The knowl-
edge gap will widen enormously.
Patients will more and more need the advice and
comfort of a caring physician. And yet, patients
more and more are increasingly believing that they
have no doctor. Many perceive that the principal
focus of medicine is moving away from its focus on
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caring. Patients feel shortchanged by the hurried
pace and brevity of their encounters with doctors.
They want their doctor back.14
This brings me to the third and most important
subject: professionalism. You may recall that when the
Clinton administration began its effort to reform
healthcare in this country, it convened a secretive
panel led by Ira Magaziner. Notable was the fact that
this panel, which would set the course and direction
of the nation’s healthcare for the future, excluded
doctors and physician organizations. We heard such
things as “if we could control Medicare fraud and
abuse there was enough money to pay for the care of
the nation’s uninsured.” Although the Clinton health
plan failed, the legacy of excluding and distrusting
doctors persists. The government has launched a
crackdown on Medicare fraud and abuse, contending
that simply the submission of an inaccurate bill may
constitute fraud. We are guilty until proven innocent,
and the government is enlisting our elderly patients as
“whistle blowers,” with bounty payment rewards to
detect allegedly fraudulent bills.15 Does this represent
mistrust only by our government, or do our patients
no longer trust us? Does the public no longer trust
doctors? Is the medical profession no longer entrust-
ed with responsibility for the nation’s health?
Professionalism is a commitment to subordinate
one’s self interest to the interest of one’s patients.
This constitutes the very foundation of trust on
which our social contract rests. Maintaining the
mutual trust in the doctor-patient relationship is the
only way to assure the public that medicine is fulfill-
ing its sacred obligation. No patient’s bill of rights,
no laws, no review panels or regulations, no whistle
blowers or watchdog federal agencies can substitute
for the fundamental TRUST and CARING that are
central to the profession of medicine.
There are several features that characterize pro-
fessionalism: (1) altruism and a commitment to a
greater good; (2) a high degree of knowledge, spe-
cial education, and training; (3) the ability and will-
ingness to apply that knowledge and skill to a greater
societal good; (4) autonomy and the right to self
regulate and society’s implicit trust in that self regu-
lation; and (5) conformance to and development of
a code of ethics, such as the Hippocratic oath.16
However, the principles of professionalism are in
direct conflict with the commercialization of medicine.
Ethical challenges exist in reconciling Hippocratic
medicine, which is based on the doctor-patient rela-
tionship, with population-based healthcare, in which
considerations of cost effectiveness and distribution of
healthcare resources are focused on achieving the
greatest good for the greatest number of people. This
puts us in conflict as professionals. Do we care for our
individual patient above all else, or do we devote our-
selves to healthcare systems that distribute services to
people on the basis of population or group outcome
measures designed to control costs and improve effi-
ciency? We, as surgeons, have always dealt closely and
directly with our individual patient. Will we still have
the right to put our patient first, above all else, in the
future? Along with the compensation issues I discussed
earlier, the managed care revolution is threatening
professionalism in several important ways.
The first threat is an attack on professional judg-
ment. One of the central characteristics of profes-
sionals is that they are empowered and obligated to
make judgments that are in the best interests of their
patients. Although scientific data and evidence have
been critical to the advancement of medicine, the
application of evidence-based medicine to treatment
algorithms eliminates the professional from the deci-
sion-making process. We see this in the current pop-
ular notion that new treatments can only be advo-
cated if validated by prospective randomized clinical
trials—a process, which by its very nature, eliminates
professional judgment. For example, to participate
in a prospective randomized clinical trial on carotid
stenting, the vascular surgeon must be able to say to
his or her patient that “in my best professional judg-
ment, I do not know which form of treatment is best
for you, endarterectomy or carotid stenting, and I,
therefore, give you the opportunity to participate in
a trial where the treatment will be chosen at ran-
dom.” In other words, “I have no advice or recom-
mendation for you, my patient.” That is not to say
that we do not need to do the study or that we do
not need to know the outcome of such a random-
ized trial, but it does pose an ethical dilemma for the
doctor’s professional judgment and commitment to
the best interests of the patient.
Evidence-based medicine is statistically oriented
and eliminates physician judgment for an individual
patient. It is population-based medicine, not indi-
vidual-based medicine, which is at the core of the
doctor-patient relationship. Brought to the extreme,
this strategy could eliminate physicians from making
therapeutic recommendations and decisions and
have technicians apply treatments based strictly on
statistically based “evidence.” I believe this would be
as detrimental for patients as it obviously would be
for the profession.
The second attack is on collegial self-regulation. A
core value of professionals is that a profession is a self-
regulating body of people. The profession sets and
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regulates training curricula and standards and oversees
peer review of practice standards. Surgery has a long
tradition of upholding standards through the
American College of Surgeons and the American
Board of Surgery. As the field of vascular surgery has
grown and evolved as its own distinct specialty with its
own body of basic fundamental knowledge and unique
clinical expertise, the need for it to regulate itself as its
own professional discipline has become apparent.
Thus evolved the Program Evaluation and
Endorsement Committee, the vascular fellowships
under Residency Review Committee review, the
Association of Program Directors in Vascular Surgery,
and the American Board of Vascular Surgery. The
importance to the vascular surgery profession of
board regulation of training standards by vascular sur-
geons has been emphasized by Dr Stanley in his
Presidential address to this Society.17 The creation of
a sub-board for vascular surgery under the umbrella
of the American Board of Surgery is evidence of the
evolution of vascular surgery as its own profession,
which requires peer self-regulation. The early work of
the sub-board has been promising, and we must work
to develop it as the mechanism by which we, as vas-
cular surgeons, exercise our obligation to self regulate
our profession. This is the standard by which the suc-
cess of the sub-board should be judged. It is encour-
aging that professional groups, rather than splitting
apart, now are beginning to join together to challenge
the attack on the overall profession by the managed-
care economy and regulatory changes occurring in
our society. We must maintain our right to self regu-
late to maintain our profession.
Although professionals receive remuneration for
what they do, this is not our primary motivation.
What really motivates physicians is membership in
one’s professional society of peers. Peers set the stan-
dards. Peer review and acceptance and a focus on peer
professional activities are central to our lives. Witness
the importance we attach to membership in the
Society for Vascular Surgery and the International
Society for Cardiovascular Surgery. If our peers do
not accept us, we are outcasts. Each hospital has its
own peer review mechanism, both formal and infor-
mal. We evaluate ourselves and our peers on an indi-
vidual basis, just as we treat our patients on an indi-
vidual basis. We monitor our own results, and, as
Norman Hertzer correctly concluded in his
Presidential address, “results are everything” in vascu-
lar surgery.18 We must demonstrate our outcomes
and results to our patients, our referring doctors, to
the payers, and to the public.
However, the current enthusiasm for outcome
analysis with large-sample, computer-generated analy-
sis of large data banks again risks missing the boat of
individual result assessment. Managed-care advocates
are purely financially driven in studying outcome
analysis. Excessive zeal in evaluating outcomes with-
out reliable risk stratification (and I have not yet seen
a reliable way to do this, given the complexity of
patients) runs the risk of focusing healthcare on
patients with good risk and denying care to the
patients at high risk and to those who are most infirm.
The third element under attack is professional
development and education. Adequate training and
the instillation of the essential ingredients and char-
acteristics of a profession require a professional com-
munity that is alive and well. Medicine is not carry-
ing out a technical exercise but living a professional
existence. There is a process of initiation into the
profession through our educational and training
programs, including internship, residency, and fel-
lowship. These long and arduous years of training
instill core values and judgment through mentorship
and professional role models. We must preserve and
protect our teaching environments.
Cooperation among different specialties is also
important in the current economic climate. Although
turf battles may have been popular in years past, it is
now increasingly clear that we must work together to
preserve the right to deliver the highest quality care to
our patients. Gone is the idea that “we will not teach
you this or that technique in the hope that we can keep
it for ourselves.” Such logic never had merit, for tech-
nology and techniques are simply techniques.
Technology cannot be owned by a specialty. Tech-
niques do not comprise a discipline or specialty—they
are simply tools. Different specialties may use new
tools and technologies in different ways, which are
appropriate for their patients and practices. We must
begin by integrating educational activities to improve
communication. Each of our multiple vascular special-
ties brings a different and complementary perspective
on the same fundamental problem: vascular disease.
We can, and we do, learn from each other, for vascular
disease is one that requires a long-term commitment
of care for each patient from professionals.
There can be no doubt that professionalism in
medicine provides an intrinsic value. Professionalism
is good for society, good for individuals in society,
the patients, and good for the professionals them-
selves. Society entrusts the health of its members to
highly skilled and well-trained individuals who have
a moral obligation to promote the health and well
being of the members of society.19
The individual members of society benefit from
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this professionalism through improved health, a
sense of well being, and moral confidence in know-
ing that the physician is there for them, ostensibly
with only one motivation—to provide the best pos-
sible medical care.
And the professionals themselves benefit. Society
provides many rewards to the professional physi-
cians, among them power, status, and wealth. But
these are not enough. Internal rewards, such as self
esteem, gratitude from patients, professional satis-
faction, and companionship and praise from col-
leagues, are also necessary. These rewards are based
on relationships, and they require time to cultivate.
The doctor-patient relationship is paramount to pro-
fessional satisfaction. And frankly, this is what is most
threatened by the managed-care revolution.
Although management guidelines and evidence-
based medicine may be effective for certain popula-
tions of well-defined and specified conditions, they
are unlikely to be effective for the patients who are the
sickest and need a doctor the most. In cases of mor-
tality, complexity, chronicity, and debility, the physi-
cian must exercise individualized care and judgment.
The doctor-patient relationship is most critical to
patients at these times of crisis and uncertainty in their
lives. They want and need someone who cares for
them and about them. As the population ages, more
patients will demand the right to have a long-term
relationship with a physician they can trust because
there is value in the relationship itself.
For the doctor, the doctor-patient relationship is
also critical, not only for our personal satisfaction as
physicians but also for the future of our specialty.
Vascular surgeons were the first to develop effective
methods of vascular therapy and reconstruction and
noninvasive vascular diagnosis. With these tools, vas-
cular surgery evolved as a specialty focused on the
short-term and long-term management of patients
with vascular disease. We have an understanding of
the natural history of vascular disease and of nonop-
erative, conservative strategies and the outcomes of
direct and indirect treatments. The direct long-term
interaction and focus on the patient as a whole is
critical in being the vascular doctor. But as technol-
ogy advances, what remains is the doctor-patient
relationship, and the maintainance of this relation-
ship is the future of vascular surgery.
The critical question is, who will fill this role?
Will vascular surgeons be professionals who provide
care to patients with vascular disease? Or will vascu-
lar surgeons become technicians who apply therapy
while allowing physicians in other specialties to
assume responsibility for vascular care? It is my belief
that the key to preserving our place as the primary
caretaker of patients with vascular disease is preserv-
ing the doctor-patient relationship.
Now I have some thoughts on the future for the
next generation of vascular surgeons.
Despite the problems that surround us, now is a
good time for vascular surgery. This is a time of great
advancement in the field, of breakthrough, funda-
mental changes in the way we think about and treat
vascular disease. The explosion of new knowledge
will continue, and you have an opportunity to be at
the forefront of this expanding knowledge base. To
this extent, you are fortunate to have the active sup-
port of the Lifeline Foundation, the National
Institutes of Health, and the industry to support
your investigations.
Seize the opportunity to learn and expand your
horizons over and above standard open vascular
reconstruction. But do not abandon the basic fun-
damentals of vascular surgical practice: learn them
and practice them well because no one else will have
the capability of direct, open reconstruction when
needed, the most definitive and powerful treatment.
The next 5 to 10 years will be tumultuous,
uncertain, and anxiety filled as the healthcare system
restructures itself. Do not lose faith. The practice as
we know it will change, but the patients’ needs will
not change. They will be there, and you must be
there for them. Keep at the forefront. In addition to
vascular reconstruction, there will be gene therapy,
catheter-based therapy, new technology, new strate-
gies, strange proposals—some will work, many will
not. But always maintain the best interests of the
patient foremost.
After 10 years, there will be an unprecedented
demand for your services. If you have been under
compensated up to this point, you will now be paid
a premium. The massive increase in patient demand
will be accompanied by an inadequate supply of
skilled vascular surgeons, particularly those with
skills in open surgical repair and reconstruction.
General surgeons will no longer have the skills for
major aortic surgery. You will be overwhelmed by
demand. This demand for your services will contin-
ue throughout your career. As demand increases,
training programs will be expanded, but given the
length of time needed to properly train vascular sur-
geons, the buildup will be slow. The proper number
of surgeons will likely be reached just about the time
the number of patients begins to decrease in 2040,
and then there will be a surplus of vascular surgeons.
Thus, this is the golden era for the next generation
of vascular surgery. Enjoy it and make the most of it.
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My advice:
1. Be receptive to new ideas and new strategies.
2. Learn endovascular skills, evaluate new technolo-
gy, and incorporate them into your practice as
appropriate while maintaining your surgical skills.
3. Generate new knowledge, for knowledge will
lead the way.
4. Work together with your colleagues in other dis-
ciplines to improve the care of patients with vas-
cular disease.
5. Preserve and promote professionalism and the
sacredness of the doctor/patient relationship.
Let me conclude by once again addressing the
special elements of time and caring. As we have seen,
the current economic climate is to reduce costs and
to reduce reimbursements for time and energy
expended. There is no compensation for more time
spent with a patient. In the case of global billing,
extra time means no extra money.
Yet time is the indispensable element that cannot
be replaced in the doctor-patient relationship. And it
is this element of time with the patient that is incom-
patible with medical care for profit.
Time is required for caring. Time is required for
professional judgment, and that time varies with the
complexity of each case. But the most important ele-
ment is the interaction and contact with the patient.
There must be communication, which is free from
the constraint of time, at least for a moment. This is
the so-called timeless moment of meaning and com-
munication. The most essential quality of the doc-
tor-patient relationship is the doctor’s presence with
the patient. The gift of healing is the act of being
there. There must be that indispensable element of
human compassion and science, knowledge, and
technology.
This human interaction takes time, but not nec-
essarily much time. There are 10 simple rules:
1. Take the time to listen. Listen for 1 minute to
your patient. The average doctor listens for about
18 seconds before interrupting the patient.
2. Make contact. Touch the patient’s hand.
3. Sit down when you talk.
4. Get personal. Ask about personal things (eg,
family).
5. Focus on the patient’s needs and listen and feel
what those needs are.
6. Determine whether the patient is really sick.
Does the patient really need treatment or just
some kindness and understanding?
7. Learn to listen, look, and feel.
8. Do not put your hand on the doorknob as you
give advice.
9. Always conclude with, “Is there something else
you want to tell me?”
10. Take the time to show the patient you care.
As we lose time and have less time to give, we risk
retreating from our covenant with the patient, we
risk retreating from our covenant with students and
residents, and we risk retreating from our covenant
with society. If we continue to retreat, we will lose
our patients and we will lose the viability of our spe-
cialty and the vitality of our profession. We will sim-
ply become providers of healthcare, controlled and
externally regulated. We will not be professionals,
and we will not like it.
In the ever increasing pace of the Internet,
instant communication, and the ubiquitous cell
phones and pagers, we are always reachable, always
in touch. But perhaps we are not listening and com-
municating. Human interaction requires spending
time, feeling, seeing, touching, smelling, and listen-
ing. We must listen to our patients and regain from
society a trust in our profession. The patients will
speak for us, the public will speak for us, IF WE
CARE FOR THEM! We need our patients’ trust
now, and we will need it even more in the next mil-
lennium.
We must find that timeless moment each day, for
ourselves, for our families and loved ones, and for
our patients. The timeless moment is a moment of
instant communication and understanding, the
communication and understanding that takes place
between a couple in love, a mother and child, true
friends, and a doctor and patient. It occurs when we
say a prayer, establish a trust, and make a commit-
ment. It is that commitment of a doctor to the
patient.
We must cherish and cultivate these timeless
moments for the future. That is our challenge and
our responsibility.
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